famotidine has been researched along with Brain Disorders in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The authors' five cases and the other seven previously reported emphasize the need for dosage adjustment of famotidine in elderly patients and in those with renal failure, and that these patients should be carefully monitored for development of central nervous system reactions, which sometimes could be very serious." | 1.30 | Central nervous system reactions associated with famotidine: report of five cases. ( Odeh, M; Oliven, A, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Odeh, M | 1 |
| Oliven, A | 1 |
1 other study available for famotidine and Brain Disorders
| Article | Year |
|---|---|
Central nervous system reactions associated with famotidine: report of five cases.
Topics: Aged; Aged, 80 and over; Anti-Ulcer Agents; Brain Diseases; Famotidine; Female; Histamine H2 Antagon | 1998 |